Evidence map›Paper›PMID 30564575›Full record

ArticleFrontiers in cell and developmental biology2018

The Transcriptome of Human Endometrial Mesenchymal Stem Cells Under TGFβR Inhibition Reveals Improved Potential for Cell-Based Therapies.

Shanti Gurung, Sarah Williams, James A Deane, Jerome A Werkmeister, Caroline E Gargett

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. New concepts on the etiology of endometriosis.The journal of obstetrics and gynaecology research · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Endometrial SUSD2Journal of personalized medicine · 2021
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shanti GurungThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
Sarah WilliamsMonash Bioinformatics Platform, Monash University, Melbourne, VIC, Australia.
James A DeaneThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
Jerome A WerkmeisterThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
Caroline E GargettThe Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
Monash University · AUHudson Institute of Medical Research · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem/stromal cells (MSCs) are multipotent cells with favorable properties for cell therapies and regenerative medicine. Human endometrium harbors a small population of perivascular, clonogenic MSCs (eMSCs) identified by the SUSD2 marker. As for other MSCs, eMSCs require extensive

Indexed as

angiogenesisanti-fibrosisculture expansionhuman endometrial MSCRNA-sequencingTGF-βR

Identifiers

PMID30564575
PMCPMC6288489
OpenAlexW2902459931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.